Its interest is understood to be serious, with the group thinking about what a bigger terminals offering could do for its customers and whether there’s something special about Tyro worth buying.
To Street Talk, it looks like one of those deals that could’ve flown through last year, but everything’s a bit harder in 2022. Deals may make sense to the execs preparing them, but it’s hard to get boards and senior management over the line.
Magellan Financial Group has announced new boss David George’s move into the chief investment officer’s seat, but it’s far from the only change at the Australian asset manager.
Canadian giant Brookfield has unleashed a new tentacle in Australia, signing its first local deal for the group’s global capital investments arm Brookfield Special Investments.
Private equity bigwig Partners Group is back for another bite of Australia’s health care sector, this time with a bid for clinical research company George Clinical.
You have received this email because you are subscribed to Street Talk First Look with the email address: [email protected]
